The 2021 Virtual Summit covers both small molecules and biologics, new technologies, concepts and case studies in areas such as:

• Formulation design for poorly soluble compounds
• The potential of nanotechnology for better deliverability
• The latest controlled released technologies
• Improving patient compliance by harnessing data and the latest smart device technology
• Optimising formulations for continuous manufacturing
• Overcoming the blood brain barrier and challenges in oral delivery of biologics
• Reformulation and biosimilars